ScienceVest

ScienceVest is a forward-thinking venture capital firm based in New York, specializing in high-impact sectors like biotechnology, artificial intelligence, robotics, genomics, and space technology. Founded in 2016, the firm targets groundbreaking innovations and supports companies at the forefront of technological advancements. Notable investments in their portfolio include companies like GRAIL, which develops advanced cancer detection methods, and Denali Therapeutics, focused on treatments for neurodegenerative diseases. These investments underscore ScienceVest's commitment to driving forward scientific and technological progress. ScienceVest’s strategy revolves around investing in companies with transformative potential. They seek out firms that not only have strong technological foundations but also promise significant societal impact. Their typical investment stage ranges from Series A to pre-IPO, ensuring that they support companies through crucial phases of growth and development. Geographically, ScienceVest has a global investment approach, though many of their investments are concentrated in innovation hubs like the United States. This broad focus allows them to tap into diverse technological ecosystems and foster global collaborations. Led by a team of experienced investors and industry experts, ScienceVest places a strong emphasis on strategic partnerships and providing operational support to their portfolio companies. This hands-on approach helps startups navigate the complexities of scaling and market entry, particularly in highly specialized fields​.